S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

RXRX Recursion Pharmaceuticals Inc

8.12

0.28 (3.57%)

Apr 26 2024 - Closed

Delayed by 15 minutes

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Recursion Pharmaceuticals (NASDAQ:RXRX)
Historical Stock Chart
From Mar 2024 to Apr 2024

Click Here for more Recursion Pharmaceuticals Charts.

Recursion Pharmaceuticals (NASDAQ:RXRX)
Historical Stock Chart
From Apr 2023 to Apr 2024

Click Here for more Recursion Pharmaceuticals Charts.

Recursion Pharmaceuticals Inc News

Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer
Tuesday 16 April 2024 (2 weeks ago) • GlobeNewswire Inc.

Recursion to Participate in Upcoming Investor Conference
Tuesday 2 April 2024 (4 weeks ago) • GlobeNewswire Inc.

Recursion Publishes Annual Environmental, Social and Governance Report
Tuesday 26 March 2024 (1 month ago) • GlobeNewswire Inc.

Recursion Announces Plans to Open New Office in London
Monday 11 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 7 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)

Recursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease Community
Friday 1 March 2024 (2 months ago) • GlobeNewswire Inc.

Recursion to Participate in Upcoming Investor Conferences
Friday 1 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Thursday 29 February 2024 (2 months ago) • Edgar (US Regulatory)

More Recursion Pharmaceuticals Inc News Articles

Canopus Biopharma (PK)

TideRock Companies (PK)

Net Savings Link (PK)

Cann American (CE)

Innovation Pharmaceuticals (CE)

Branded Legacy (PK)

1812 Brewing (PK)

AMC Entertainment

NioCorp Developments

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions